Somnoplasty system set for launch in Japan:
This article was originally published in Clinica
Executive Summary
Somnus Medical Technologies has received Japanese approval to market its radiofrequency-based Somnoplasty system for treating obstructive sleep apnoea, chronic nasal obstruction and habitual snoring. The control unit and single use disposable devices have already been cleared in the US and will be launched in Japan shortly. Sunnyvale, California-based Somnus said that industry reports have estimated that around 7.5% of Japanese adults aged 18-68 suffer from some form of obstructive sleep apnoea. This is more than twice the rate in the US.